HealthMore in Health→
CMS Doubles Innovation Team to Drive Down Medicare Drug Costs
Key Takeaways
- CMS Innovation Center is more than doubling its dedicated drug pricing team to run new pilot programs
- Expansion targets Medicare and Medicaid prescription costs through multiple concurrent model tests
- The move complements the Inflation Reduction Act's direct drug negotiation provisions already in effect for 2026
DE
DT Editorial Team··3 min read·via endpoints.news